SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Google

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Antivirals may help monkeypox patients
Wed May 25th - Antiviral medications may be effective against monkeypox, researchers have found, but more research is urgently needed. More
Anti-ageing drugs prevent radiotherapy impact
Wed May 25th - The long-term impact of radiation therapy for cancer could be limited with a class of drugs called senolytics, researchers say. More
RECENT COMMENTS
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
OUR CLIENTS
THIS WEEK'S STORIES
Pharmaceuticals

Pharmaceuticals

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65

29/10/2020 - COVID-19 antibody therapy candidates identified
UK scientists have identified a potentially ground-breaking antibody combination that could be used as a “cocktail” against COVID-19, it is revealed today. More

28/10/2020 - Vitamin D linked to respiratory disease including COVID-19
A large proportion of patients hospitalised with COVID-19 have a deficiency of vitamin D, according to a new analysis. More

28/10/2020 - Drug trial for Parkinson hallucinations
An anti-nausea drug is being tested to see if it can reduce the hallucinations which affect people with Parkinson’s disease. More

26/10/2020 - New generation BRAF inhibitor shows promise
A drug designed to work against a range of BRAF mutations in several cancers is showing early promise, a European conference heard last night. More

22/10/2020 - COVID-19 vaccine trials do not assess severe disease
Mass vaccination could be introduced against COVID-19 without any evidence indicating it could save lives, an expert warns today. More

21/10/2020 - Asthma treatments linked to bone health
Some asthma treatments may be linked to a raised risk of osteoporosis and fracture, researchers warn today. More

21/10/2020 - Measures to prevent dementia 'cost-effective'
Interventions for preventing dementia in England could be cost-effective, saving over a billion pounds per year, and could significantly reduce dementia rates, according to a new analysis. More

19/10/2020 - Drugs disappointment triggers call for COVID-19 investment
The world will need to pump billions more into COVID-19 studies after a series of disappointing drug trials, experts have said. More

13/10/2020 - Appeal for new vaccine volunteers
An appeal was launched today for minority groups to sign up to take part in the UK’s trials of COVID-19 vaccines. More

06/10/2020 - 'Game changer' paediatric neuroblastoma drug trial announced
A recently developed drug could be a “game changer” treatment for children with neuroblastoma, it was announced today. More

06/10/2020 - No evidence of antiviral benefit against COVID-19 - major trial
A powerful antiviral drug combination has proved ineffective in treating COVID-19 infection, according to the latest findings from a major study. More

02/10/2020 - Treatment hope for HER2+ breast cancer patients
Women with early HER2+ breast cancer survive longer if they are prescribed lapatinib and trastuzumab before surgery, the results of a Spanish trial have revealed More

01/10/2020 - Care homes to test anti-inflammatory virus treatment
An anti-tumour necrosis factor drug is to be tested as a community treatment for COVID-19 infection, it has been announced. More

30/09/2020 - Assessing treatment for older breast cancer patients
Many elderly breast cancer patients should be considered for more intensive treatment than is currently offered, researchers have found. More

30/09/2020 - DNA repair drug benefits advanced cancer
A novel treatment for advanced cancer has shown promising results in a recent trial, British researchers have announced. More

22/09/2020 - Embrace medicinal cannabis, say experts
Attitudes towards medicinal cannabis use must change among the medical and pharmaceutical sector in the UK, according to an analysis published today. More

22/09/2020 - Combination treatment could attack aggressive prostate cancers
An experimental cancer drug combined with targeted hormone treatment could treat an aggressive group of prostate cancers, a European conference has heard. More

21/09/2020 - Access to cancer medicines and trials vary across Europe
Access to cancer medicines varies widely across Europe both for new drugs in development and for currently approved drugs, a conference has heard. More

15/09/2020 - Contraception cash scheme cut abortions
A scheme that rewarded GPs for promoting long-acting reversible contraception may have helped reduce abortion rates, according to a new study. More

11/09/2020 - Europe struggles with vaccine doubts
Europe may struggle to get the public to use any approved COVID-19 vaccine, according to an analysis published yesterday. More

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65

Printer friendly page Printer friendly page

CATEGORIES